Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
374.56B | 366.74B | 351.11B | 354.91B | 355.90B | 271.52B | Gross Profit |
104.57B | 106.45B | 100.30B | 101.80B | 101.98B | 75.71B | EBIT |
12.60B | 13.48B | 10.30B | 11.30B | 11.73B | 7.15B | EBITDA |
17.83B | 17.42B | 14.60B | 15.18B | 14.18B | 9.20B | Net Income Common Stockholders |
8.61B | 8.31B | 6.17B | 7.59B | 5.30B | 2.94B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
37.70B | 12.36B | 13.20B | 14.22B | 19.60B | 15.02B | Total Assets |
141.43B | 133.25B | 119.39B | 117.18B | 130.81B | 119.86B | Total Debt |
0.00 | 1.64B | 1.87B | 2.03B | 2.17B | 2.92B | Net Debt |
-10.20B | -10.71B | -11.33B | -12.19B | -17.42B | -12.09B | Total Liabilities |
56.95B | 52.65B | 45.62B | 47.76B | 56.53B | 49.19B | Stockholders Equity |
84.48B | 80.59B | 73.77B | 69.39B | 74.24B | 70.62B |
Cash Flow | Free Cash Flow | ||||
0.00 | 11.88B | 3.42B | 997.00M | 13.18B | 1.25B | Operating Cash Flow |
0.00 | 18.23B | 10.50B | 6.36B | 18.85B | 4.63B | Investing Cash Flow |
0.00 | -6.49B | -7.15B | -5.41B | -5.93B | 2.11B | Financing Cash Flow |
0.00 | -2.12B | -2.19B | -12.87B | -2.31B | -1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥60.10B | 11.78 | 1.72% | 13.93% | -11.16% | ||
78 Outperform | ¥153.37B | 12.37 | 1.63% | 10.21% | 16.03% | ||
78 Outperform | ¥186.12B | 10.85 | 2.60% | 5.04% | 8.60% | ||
77 Outperform | ¥102.31B | 10.92 | 2.18% | 2.91% | 12.82% | ||
74 Outperform | ¥104.42B | 11.70 | 1.23% | 7.83% | 3.68% | ||
68 Neutral | ¥58.93B | 11.04 | 2.83% | 5.78% | 10.78% | ||
65 Neutral | $8.88B | 15.05 | 4.75% | 203.76% | 3.54% | -2.50% |